Search results
Moderna’s COVID, flu combination vaccine shows stronger immune response, company announces
WFTV 9 Orlando· 4 days agoModerna is working on a single vaccine that it says will protect people against both COVID-19 and...
Moderna develops combination COVID-19 and flu shot
WBAY Green Bay· 3 days agoModerna says the combination triggered a better immune response than the COVID-19 and flu shots alone.
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 4 days agoIt plans to present full results at an upcoming medical meeting, and to discuss next steps with...
Why Moderna Stock Is a No-Brainer Buy Right Now
The Motley Fool via AOL· 4 days agoCMV is the top infectious cause of birth defects in the U.S. and currently has no approved vaccines. With Merck, Moderna is testing a combination of Merck's ...
Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season
FierceBiotech· 4 days agoModerna’s combo flu and COVID-19 vaccine zipped through a late-stage trial this winter, and the...
Pentagon ran secret anti-vax campaign to incite fear of China vaccines
Reuters· 8 hours agoThe clandestine operation has not been previously reported. It aimed to sow doubt about the safety...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
Morningstar· 7 days agoNEW YORK, June 7, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ ...
Moderna director Noubar Afeyan sells over $2.2m in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has recently sold a substantial number of shares...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 4 days agoPfizer-BioNTech and Novavax are also working on their own COVID-flu vaccines, but Moderna is the...
Here's To Science! Pfizer, Moderna Look To Combo Flu/COVID Vaccines
MediaPost· 4 days agoAlbert Bourla, Pfizer’s chief executive officer, acknowledged on Monday that, because the company’s stock price was down at the time, he gave the final sign-off on running the ad (which reportedly ...